Health Canada Green Lights Subcutaneous Atezolizumab for Lung, Breast, and Liver Cancer

Health Canada has approved subcutaneous atezolizumab for use in patients with lung cancer, breast cancer, and hepatocellular carcinoma.

Related Keywords

Canada ,Ottawa ,Ontario ,Michelle Forman ,Sara Moore ,Health Canada ,Burnaby Hospital Cancer Centre ,European Commission ,Ottawa Hospital ,Subcutaneous Atezolizumab ,Hepatocellular Carcinoma ,Lung ,Breast ,